CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 70 enrolled
Drug / intervention
Celecoxib +5 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03818919
NCT03818919Phase 2Completed

Traditional vs. Nonopioid Analgesia After Rotator Cuff Repair

Henry Ford Health System·interventional·Posted Jan 28, 2019·Updated Apr 2, 2024

In Brief

A Phase 2 clinical trial evaluating Celecoxib, Ketorolac, and 4 other interventions for Rotator Cuff Tear. Completed, enrolled 70 participants across 1 site.

Detailed Summary

This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20192020202120222023202420252026
First PostedJan 28, 2019
Enrollment StartJan 22, 2019
Primary CompletionDec 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 7.4 years ago

Interventions

Celecoxibdrug

Post-Operative Non Opioid Pain Protocol

Ketorolacdrug

Post-Operative Non Opioid Pain Protocol

Gabapentindrug

Post-Operative Non Opioid Pain Protocol

Acetaminophendrug

Post-Operative Non Opioid Pain Protocol

Diazepamdrug

Post-Operative Non Opioid Pain Protocol

Hydrocodone-Acetaminophendrug

Traditionally used narcotic pain protocol